PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE anti-human CD314 (NKG2D), 25 tests
PE anti-human CD317 (BST2, Tetherin), 100 tests
PE anti-human CD317 (BST2, Tetherin), 25 tests
PE anti-human CD318 (CDCP1), 100 tests
PE anti-human CD318 (CDCP1), 25 tests
PE anti-human CD319 (CRACC), 100 tests
PE anti-human CD32, 100 tests
PE anti-human CD32, 25 tests
PE anti-human CD323 (JAM3), 100 tests
PE anti-human CD323 (JAM3), 25 tests
PE anti-human CD324 (E-Cadherin), 100 tests
PE anti-human CD324 (E-Cadherin), 25 tests
PE anti-human CD325 (N-Cadherin), 100 tests
PE anti-human CD325 (N-Cadherin), 25 tests
PE anti-human CD326 (EpCAM), 100 tests
PE anti-human CD326 (Ep-CAM), 100 tests